High-density lipoprotein subspecies between patients with type 1 diabetes and type 2 diabetes without/with intensive insulin therapy

Endocrine Journal

Volumn 59, Issue 7, 2012, Pages 561-569

  Fukui, Tomoyasu ^a   Hirano, Tsutomu ^a  

^a SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

High density lipoprotein subspecies; Intensive insulin therapy; Type 1 diabetes; Type 2 diabetes

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN 2; HIGH DENSITY LIPOPROTEIN 3; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ORAL ANTIDIABETIC AGENT; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRECIPITATION; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL;

ADMINISTRATION, ORAL; ADULT; AGED; CASE-CONTROL STUDIES; COMBINED MODALITY THERAPY; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIET THERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; EXERCISE THERAPY; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; LIPOPROTEINS, HDL; MALE; MIDDLE AGED;

EID: 84865655647     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.EJ11-0329     Document Type: Article

References (33)

1. N E Miller, F Hammett, S Saltissi, et al. (1981) Relation of angiographically defined coronary artery disease to plasma lipoprotein subfractions and apolipoproteins. Br Med J 282:1741-1744.
2. Syvänne M, Ahola M, Lahdenperä S, et al. (1995) High density lipoprotein subfractions in non-insulin-dependent diabetes mellitus and coronary artery disease. J Lipid Res 36:573-582.
3. Laakso M (1997) Dyslipidemia, morbidity, and mortality in non-insulin-dependent diabetes mellitus. Lipoproteins and coronary heart disease in non-insulindependent diabetes mellitus. J Diabetes Complications 11:137-141.
4. Kontush A, Chapman MJ (2006) Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis. Pharmacol Rev 58:342-374.
5. Chapman MJ, Goldstein S, Lagrange D, et al. (1981)A density gradient ultracentrifugal procedure for the isolation of the major lipoprotein classes from human serum. J Lipid Res 22: 339-358.
6. M. Chr, Bakogianni, Chr, A. Kalofoutis, K. I. Skenderi, et al. (2001) Clinical evaluation of plasma high-density lipoprotein subfractions (HDL2, HDL3) in non-insulin- dependent diabetics with coronary artery disease. J Diabetes Complications 15:265-269.
7. Drexel H, Amann FW, Rentsch K, et al. (1992) Relation of the level of high-density lipoprotein subfractions to the presence and extent of coronary artery disease. Am J Cardiol 70:436-440.
8. Lamarche B, Moorjani S, Cantin B, et al. (1997) Associations of HDL2 and HDL3 subfractions with ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study. Arterioscler Thromb Vasc Biol 17:1098-1105.
9. Pérez-Méndez O, Torres-Tamayo M, Posadas-Romero C, et al. (2007) Abnormal HDL subclasses distribution in overweight children with insulin resistance or type 2 diabetes mellitus. Clin Chim Acta 376:17-22.
10. Hirano T, Nohtomi K, Koba S, et al. (2008) A simple and precise method for measuring HDL-cholesterol subfractions by a single precipitation followed by homogenous HDL-cholesterol assay. J Lipid Res 49:1130-1136.
11. Kantartzis K, Rittig K, Cegan A, et al. (2008) Fatty liver is independently associated with alterations in circulating HDL2 and HDL3 subfractions. Diabetes Care 31:366-368.
12. Warnick GR, and Albers JJ (1978) A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol. J Lipid Res 19:65-76.
13. Ito Y, Fujimura M, Ohta M, et al. (2011) Development of a homogeneous assay for measurement of small dense LDL cholesterol. Clin Chem 57:57-65.
14. The Committee of Japan Diabetes Society on the Diagnostic Criteria of Diabetes Mellitus (2010) Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. J Japan Dia Soc 53:450-467 (In Japanese).
15. Mattock MB, Salter AM, Fuller JH, et al. (1982) High density lipoprotein subfractions in insulin-dependent diabetic and normal subjects. Atherosclerosis 45:67-79.
16. Dullaart RP (1995) Plasma lipoprotein abnormalities in type 1 (insulin-dependent) diabetes mellitus. Neth J Med 46:44-54.
17. Eckel RH, Albers JJ, Cheung MC, et al. (1981) High density lipoprotein composition in insulin-dependent diabetes mellitus. Diabetes 30:132-138.
18. Kahri J, Groop PH, Viberti G, et al. (1993) Regulation of apolipoprotein A-I-containing lipoproteins in IDDM. Diabetes 42:1281-1288.
19. G.D. Calvert, T. Mannik, J.J. Graham, et al. (1978) Effects of therapy on plasma-high-density-lipoprotein- cholesterol concentration in diabetes mellitus. The Lancet 312:66-68.
20. Helen M. Colhoun, James D. Otvos, Mike B. Rubens, et al. (2002) Lipoprotein subclasses and particle sizes and their relationship with coronary artery calcification in men and women with and without type 1 diabetes. Diabetes 51:1949-1956.
21. Pacifico A, Cherchi GM, Baggi MA, et al. (1983) Changes in HDL subfractions in patients with type I diabetes mellitus before and after metabolic control. Boll Soc Ital Biol Sper 59:1618-1624.
22. Taskinen MR, Kuusi T, Helve E, et al. (1988) Insulin therapy induces antiatherogenic changes of serum lipopro teins in noninsulin-dependent diabetes. Arteriosclerosis 8:168-177.
23. J R Patsch, S Prasad, A M Gotto, Jr., et al. (1987) High density lipoprotein2 Relationship of the plasma levels of this lipoprotein species to its composition, to the magnitude of postprandial lipemia, and to the activities of lipoprotein lipase and hepatic lipase. J Clin Invest 80: 341-347.
24. Geremia Romano, Lidia Patti, Francesca Innelli, et al. (1997) Iulin and sulfonylurea therapy in NIDDM patients. Are the effects on lipoprotein metabolism different even with similar blood glucose control? Diabetes 46:1601-1606.
25. Kaoru Arii, Tadashi Suehiro, Michiya Yamamoto, et al. (1997) Suppression of plasma cholesteryl ester transfer protein activity in acute hyperinsulinemia and effect of plasma nonesterified fatty acid. Metabolism 46:1166-1170.
26. Johansson J, Carlson LA, Landou C, et al. (1991) High density lipoproteins and coronary atherosclerosis. A strong inverse relation with the largest particles is confined to normotriglyceridemic patients. Arterioscler Thromb 11:174-182.
27. Drexel H, Amann FW, Rentsch K, et al. (1992) Relation of the level of high-density lipoprotein subfractions to the presence and extent of coronary artery disease. Am J Cardiol 70: 436-440.
28. Skinner ER (1994) High-density lipoprotein subclasses. Curr Opin Lipidol 5: 241-247.
29. Barter P, Kastelein J, Nunn A, et al. (2003) High density lipoproteins (HDLs) and atherosclerosis; the unanswered questions. Atherosclerosis 168:195-211.
30. Desai MY, Rodriguez A, Wasserman BA, et al. (2005) Association of cholesterol subfractions and carotid lipid core measured by MRI. Arterioscler Thromb Vasc Biol 25: e110-e111.
31. Ohta T, Saku K, Takata K, et al. (1995) Different effects of subclasses of HDL containing apoA-I but not apoA-II (LpA-I) on cholesterol esterification in plasma and net cholesterol efflux from foam cells. Arterioscler Thromb Vasc Biol 15: 956-962.
32. Duriez P and Fruchart JC (1999) High-density lipoprotein subclasses and apolipoprotein A-I. Clin Chim Acta 286: 97-114.
33. Holman RR, Paul SK, Bethel MA, et al. (2008) 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 359:1577-1589.